Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
10/2005
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951952 which exhibit a first color when in crystalline form and a second different color when in the liquid, amorphous form; for thermal imaging
10/04/2005US6951713 Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
09/2005
09/29/2005WO2005090335A1 Epothilone derivatives
09/29/2005WO2005089490A2 Novel compounds and methods for inhibiting cellular responses to hypoxia
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005CA2556915A1 Epothilone derivatives
09/28/2005EP1580183A1 Process for determining the purity of anhydrosugar alcohols
09/28/2005EP1578747A2 Novel herbicides
09/28/2005CN1675220A Epothilone derivatives
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675179A Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
09/28/2005CN1220692C Process for preparing cephalotaxane derivatives
09/22/2005WO2005087728A1 Resistance-repellent retroviral protease inhibitors
09/22/2005WO2005087225A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
09/22/2005US20050209301 Resistance-repellent retroviral protease inhibitors
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050208155 New DNA polymerase inhibitors, mikanolide and dihydromikanolide
09/22/2005CA2559328A1 Resistance-repellent retroviral protease inhibitors
09/21/2005CN1671713A Novel derivative of flavone c-glycoside and composition containing the same
09/21/2005CN1671709A Pyrazolopyrimidines and the use thereof for controlling harmful organisms
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671622A Microporous crystalline zeolite material (zeolite ITQ-22), synthesis method thereof and use of same as a catalyst
09/21/2005CN1671380A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
09/20/2005US6946561 Desorption; reverse phase chromatography
09/20/2005US6946456 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
09/15/2005WO2005085255A1 The extract of bulbophgllum radiatum lindl and the preparation and the use
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005084222A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/15/2005US20050203269 Novel dicarboxylic acids are described herein that are suitable for the preparation of high-temperature-stable polymers, which are particularly useful in forming suitable dielectrics in microelectronics.
09/15/2005US20050202107 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/15/2005CA2556692A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/14/2005EP1572697A1 Novel spirobenzofuranlactams and the derivatives thereof, methods for the production thereof, and use thereof
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
09/14/2005CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/14/2005CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/14/2005CN1218949C Artemisine arylether derivatives and their preparing process
09/13/2005US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/13/2005US6943194 oxidizing 3-(tert-butyl dimethylsilyl)oxy-4-methoxybenzaldehyde with potassium permanganate to form carboxylic acid, converting to corresponding acid chloride, protecting with a butyllithium derivative, deprotecting to form phenstatin
09/13/2005US6943178 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
09/09/2005WO2005083045A1 Perfuming ingredients capable of imparting woody odors
09/09/2005WO2005062913A3 Triplide 5,6-derivatives as immunomodulators and anticancer agents
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1569940A1 Single pot conversion of artemisinin to artesunic acid
09/07/2005EP1569939A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
09/07/2005EP1495012B1 Recovery and purification of anhydro sugar alcohols from a vapor stream
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665772A Chiral dopant with phenylethanediol functionality
09/07/2005CN1663956A Process for extracting and separating aloe chromone from aloe leaves
09/07/2005CN1663955A Pyridines podophyllotoxin compounds and their preparation method and use in preparation of pesticides
09/01/2005WO2005079793A1 Prostaglandin d2 antagonist
09/01/2005DE102004004906A1 New oxygen-bridged angucyclinone derivatives, useful for treating bacterial infections and dementia, are modulators of intracellular calcium levels
08/2005
08/31/2005EP1568781A2 Melanogenesis-modulating macrolides assessed by mammalian cell based activity assays
08/31/2005EP1567530A1 Single pot conversion of artemisinin into arteether
08/31/2005EP1567529A2 Pseudopolymorphic forms of a hiv protease inhibitor
08/31/2005CN1660852A New typed sugar of C12 high carbon and ramification, preparation method and application
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/30/2005US6936725 Photochromic compounds
08/30/2005US6936723 Anticancer activity and V-ATPase inhibition; improved stability over natural benzolactones
08/30/2005US6936628 Orally administering one or more pharmaceutically acceptable acid neutralizing buffers with epothiolones (simultaneously, before or after) to increase the vioavailability of epothiolones
08/30/2005US6936285 Use of Ginkgo biloba extracts for preparing a medicine
08/25/2005WO2005023818A3 Heterobicyclic compounds as pharmaceutically active agents
08/25/2005US20050187287 Improved tubulin polymerization
08/25/2005US20050187281 Spirocyclic cyclohexane derivatives
08/25/2005US20050187270 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/25/2005US20050187110 Novel herbicides
08/24/2005CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases
08/24/2005CN1216058C Reverse sublimation substance trapping method and its equipment
08/24/2005CN1216051C Macrocyclic analogs and method of their use and preparation
08/24/2005CN1216030C O-acyl-alpha-hydroxycarboxylic ester compounds and their preparation method
08/23/2005US6933396 Process to prepare psorospermin
08/23/2005US6933385 A pentanoic amide derivatives as chemical intermediates for antitumor agents
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/23/2005US6932990 Comprises solvent extract of compressed cake derived from defatted evening primrose seed wherein effective component contains polyphenol-essential elements such as ellagic acid, gallic acid, pentagalloylglucose and catechin
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005074933A1 Small molecule inhibitors of her2 expression
08/18/2005US20050182129 Hair growth tonic
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/17/2005EP1564217A2 Process for the production of epothilones
08/17/2005EP1562598A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
08/17/2005EP1562580A1 Intermediates for aromatic polyketides as selective anticancer and antiviral agents
08/17/2005CN1654040A Novel medical uses of perennial sowthistle and preparing method for intermediate thereof
08/17/2005CN1215071C Erigeron ester B and its preparation method as well as application in pharmacy
08/17/2005CN1215070C Use of praeruptorin C in preparing medicine for curing tumor
08/16/2005US6930187 Method of preparation of 21-amino epothilone derivatives
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/10/2005EP1560835A1 Spirocyclic cyclohexane derivatives
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 174